|

Nogapendekin Alfa Inbakicept Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ALT 803, ALT-803, ALT803, Anktiva, Fusion Protein Consisting of IL-15N72D and IL-15RASU/FC +10 more

Pipeline

Early 1: 1

Top Sponsors

  • Northwestern University1

Indications

  • Round Cell Liposarcoma1
  • Myxoid Liposarcoma1
  • Synovial Sarcoma1
  • Cancer1

Chicago, Illinois1 trial

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

Northwestern University

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.